Submitted by comunicaciones on Thu, 03/27/2025 - 19:47
ECBE
pacientes con diabetes mellitus tipo 2 atendidos en la consulta externa del HUN
seccion ECBE
Referencias
Body
  1. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 10 de diciembre de 2012;36(Supplement_1):S67-74.
  2. American Diabetes Association Professional Practice Committee. Introduction and Methodology: Standards of Care in Diabetes-2024. Diabetes Care. 1 de enero de 2024;47(Supplement_1):S1-4.
  3. Blonde L, Umpierrez GE, Reddy SS, McGill JB, Berga SL, Bush M, et al. American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update. Endocr Pract. 1 de octubre de 2022;28(10):923-1049.
  4. Davies MJ, Aroda VR, Collins BS, Gabbay RA, Green J, Maruthur NM, et al. Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 28 de septiembre de 2022;45(11):2753-86.
  5.  Diabetes Canada | Clinical Practice Guidelines [Internet]. [citado 4 de mayo de 2024]. Disponible en: https://guidelines.diabetes.ca/cpg
  6. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. noviembre de 2019;157:107843.
  7. Vargas-Uricoechea H, Casas-Figueroa LÁ. [Epidemiology of diabetes mellitus in South America: The experience of Colombia]. Clin E Investig En Arterioscler Publicacion Of Soc Espanola Arterioscler. 2016;28(5):245-56.
  8. American Diabetes Association Releases 2023 Standards of Care in Diabetes to Guide Prevention, Diagnosis, and Treatment for People Living with Diabetes | ADA [Internet]. [citado 4 de mayo de 2024]. Disponible en: https://diabetes.org/newsroom/american-diabetes-association-2023-standardscare-diabetes-guide-for-prevention-diagnosis-treatment-people-living-withdiabetes
  9. Overview | Type 2 diabetes in adults | Quality standards | NICE [Internet]. NICE; 2023 [citado 4 de mayo de 2024]. Disponible en: https://www.nice.org.uk/guidance/qs209
  10. Sitio Web «Acercando el IMSS al Ciudadano» [Internet]. [citado 4 de mayo de 2024]. Edit with ZoteroDisponible en: https://www.imss.gob.mx/node/85253
  11. Guías ALAD sobre el Diagnóstico, Control y Tratamiento de la Diabetes Mellitus Tipo 2 con Medicina Basada en Evidencia Edición 2019 - ALAD - Asociación Latinoamericana de Diabetes [Internet]. [citado 4 de mayo de 2024]. Disponible en: https://aladlatam.org/guias-clinicas/guia-alad-edicion-2019/
  12. Iragorri N. Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años. 2016.
  13. LeRoith D, Biessels GJ, Braithwaite SS, Casanueva FF, Draznin B, Halter JB, et al. Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 1 de mayo de 2019;104(5):1520- 74.
  14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge. Clin Chem. 1 de junio de 1972;18(6):499-502.
  15. Cosmea A. Las tablas de riesgo cardiovascular: Una revisión crítica. Medifam. 1 de marzo de 2001;11
  16. Rodríguez-Ariza CD, Cabrera-Villamizar A, Rodríguez-Pulido AL, Callegari S, Ossa Rodríguez NA, Pinilla-Roncancio M, et al. External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort. Sci Rep. 15 de abril de 2023;13(1):6139..
  17. Rosenzweig JL, Bakris GL, Berglund LF, Hivert MF, Horton ES, Kalyani RR, et al. Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab. 1 de septiembre de 2019;104(9):3939-85.
  18. Wang X, Lu Y, Wang Y, Chen WB. Diabetic Retinopathy Stage Classification Using Convolutional Neural Networks. 2018 IEEE Int Conf Inf Reuse Integr IRI. julio de 2018;465-71.
  19. 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases [Internet]. [citado 4 de mayo de 2024]. Disponible en: https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/2019- guidelines-on-diabetes-pre-diabetes, https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/2019- guidelines-on-diabetes-pre-diabetes
  20. Knuuti J, Wijns W, Saraste A, Capodanno D, Barbato E, Funck-Brentano C, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur Heart J. 14 de enero de 2020;41(3):407-77.
  21. MDCalc [Internet]. [citado 5 de mayo de 2024]. CKD-EPI Equations for Glomerular Filtration Rate (GFR). Disponible en: https://www.mdcalc.com/calc/3939/ckd-epi-equations-glomerular-filtration-rategfr
  22. Nordanstig J, Behrendt CA, Baumgartner I, Belch J, Bäck M, Fitridge R, et al. Editor’s Choice -- European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Asymptomatic Lower Limb Peripheral Arterial Disease and Intermittent Claudication. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg. enero de 2024;67(1):9-96.
  23. Aboyans V, Ricco JB, Bartelink MLEL, Björck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 1 de marzo de 2018;39(9):763-816.
  24. Schaper NC, van Netten JJ, Apelqvist J, Bus SA, Fitridge R, Game F, et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev. marzo de 2024;40(3):e3657.
  25. Pinilla AE, Barrera M del P, Sánchez AL, Mejía A. Factores de riesgo en diabetes mellitus y pie diabético: un enfoque hacia la prevención primaria. Rev Colomb Cardiol. 1 de julio de 2013;20(4):213-22.
  26. Frid AH, Kreugel G, Grassi G, Halimi S, Hicks D, Hirsch LJ, et al. New Insulin Delivery Recommendations. Mayo Clin Proc. 1 de septiembre de 2016;91(9):1231-55